Marina Temkin
In 2019, VC deal value surpassed $135bn, exit activity reached all-time high and the median new fund size approached $80m found a new report by PitchBook and the NVCA.
Silicon Valley Bank's report on 2019 healthcare VC trends, shows that funding increased while investment activity declined slightly.
The latest CB Insights report analyzes the most promising and highly-valued tech companies in the US that could potentially make a public debut in 2020. Top investors include Tiger, Sequoia and AH.
Longitude Capital, LLR Partners, Summit Partners and Insight Venture Partners lead COPERA's performance, according to a December 2018 report.
Oscillations in seed financing did not prevent the San Francisco LP from continuing to raise larger funds and amassing $1.1bn in AUM.
The State Investment Council increases VC allocation with hopes of boosting state's entrepreneurial economy. It expects to commit between $75 mln and $125 mln to VC in 2020.
A Probitas survey finds that more LPs are investing in venture compared with last year,
While billions of dollars are going towards AI in healthcare, AI is nowhere near to revolutionizing how patients are treated. For now, imaging and diagnostics are the most promising medical applications of AI.
Regulator's rejection means companies without a surplus of capital will not yet be able to take advantage of the novel approach when going public.
Alaska Permanent Fund is the latest public LP to bet on NEA 17, which is targeting $3.6 billion.